您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>生物技术

2016-2021年全球多重鉴定市场研究报告
Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021

2016-2021年全球多重鉴定市场研究报告
【报告编号】:No.25895
【发布时间】:2016-08
【关 键 字】:multiple assay     多重鉴定       
【报告页数】:174页
【报告价格】:电子版:5650美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 生物技术行业的相关报告
Report Description
 
Adoption of Companion Diagnostics for Increasing Efficacy of Therapies, Advantages of Multiplexing Over Traditional Assays, and Need for Effective Analytical Platforms in Research to Reduce Operational Costs, and Will Boost the Growth of the Multiplex Assays Market.
 
The multiplex assays market is projected to reach USD 3.76 billion by 2021 USD 2.66 billion in 2016, growing at a CAGR of 7.2% during the forecast period (2016–2021). In this report, the multiplex assays market is broadly segmented on the basis of product & service, type, technology, applications, end user, and region.
 
The multiplex assays market, based on the type, is categorized into nucleic acid-based assays and protein-based assays. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays. The protein based assays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to adoption of these assays in research purpose. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. Based on the technology, the multiplex assays market is categorized into multiplex polymerase chain reaction, multiplex arrays, and other technologies. The multiplex arrays segment is further divided into planar arrays and bead-based arrays. The multiplex arrays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to technological advancements emerging in this segment.
 
The U.S. is expected to account for the largest share of the multiplex assays market in 2016. Europe is the second-largest source for multiplex assays market; this regional market is driven by the availability of government funds for the research and development of multiplex assays. Asia-Pacific region is estimated to be the fastest growing region in the multiplex assays market during the forecast period due to the adoption of multiplex assays in this region.
 
New product launches is the dominant strategy adopted by key industry participants in the multiplex assays market to increase their market share and cater to unmet needs.
 
Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).
 
Reasons to buy this report:
This research report has focused on various levels of analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth market segments; high-growth regions; and market drivers, restraints, and opportunities.
 
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on multiplex assays products and services offered by the top players in the global multiplex assays market
• Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the multiplex assays market
• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for multiplex assays across regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global multiplex assays market 
• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the leading players in the global multiplex assays market
 
Table of Contents
 
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 20
1.5 STAKEHOLDERS 20
 
2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 22
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.2.1 KEY DATA FROM SECONDARY SOURCES 26
2.2.2 KEY DATA FROM PRIMARY SOURCES 26
2.2.2.1 Key industry insights 27
2.2.3 ASSUMPTIONS FOR THE STUDY 28
2.2.4 REPORT LIMITATIONS 29
 
3 EXECUTIVE SUMMARY 30
3.1 INTRODUCTION 30
3.2 CURRENT SCENARIO 30
3.3 FUTURE OUTLOOK 31
3.4 CONCLUSION 36
 
4 PREMIUM INSIGHTS 37
4.1 MULTIPLEX ASSAYS: MARKET OVERVIEW 37
4.2 GEOGRAPHICAL ANALYSIS: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES (2016) 38
4.3 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET 39
4.4 MULTIPLEX ASSAYS MARKET, BY END USER 39
4.5 MULTIPLEX ASSAYS MARKET, BY TYPE 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 44
5.3.1.1 Adoption of companion diagnostics for increasing safety & efficacy of therapies 44
5.3.1.2 Need for effective analytical platforms to reduce operational costs 44
5.3.1.3 Advantages of multiplexing over traditional assays 45
5.3.2 RESTRAINTS 45
5.3.2.1 High investment cost of multiplex assay equipment 45
5.3.2.2 Standardization of immunoassay design and quality control 45
5.3.3 OPPORTUNITIES 46
5.3.3.1 Increasing validation of biomarkers in molecular and protein diagnostics 46
5.3.3.2 Need for high-throughput and automated systems 46
5.3.4 CHALLENGES 47
5.3.4.1 Dearth of skilled labor 47
5.3.4.2 Development of assays for all disease classes 47
 
6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICES 48
6.1 INTRODUCTION 49
6.2 MULTIPLEX ASSAY CONSUMABLES 50
6.3 MULTIPLEX ASSAY INSTRUMENTS 52
6.4 MULTIPLEX ASSAY ACCESSORIES 53
6.5 SOFTWARE AND SERVICES 54
 
7 MULTIPLEX ASSAYS MARKET, BY TYPE 55
7.1 INTRODUCTION 56
7.2 NUCLEIC ACID-BASED MULTIPLEX ASSAYS 57
7.2.1 PLANAR NUCLEIC ACID ASSAYS 59
7.2.2 BEAD-BASED NUCLEIC ACID ASSAYS 60
7.3 PROTEIN-BASED MULTIPLEX ASSAYS 62
7.3.1 PLANAR PROTEIN ASSAYS 64
7.3.2 BEAD-BASED PROTEIN ASSAYS 66
8 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY 67
8.1 INTRODUCTION 68
8.2 MULTIPLEX PCR 69
8.3 MULTIPLEX ARRAYS 70
8.3.1 MULTIPLEX PLANAR ARRAYS 71
8.3.2 MULTIPLEX BEAD-BASED ARRAY 73
8.4 OTHER TECHNOLOGIES 74
 
9 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION 75
9.1 INTRODUCTION 76
9.2 RESEARCH & DEVELOPMENT 77
9.2.1 DRUG DEVELOPMENT 79
9.2.2 BIOMARKER DISCOVERY AND VALIDATION 80
9.3 DISEASES & DISORDERS 81
9.3.1 INFECTIOUS DISEASES 83
9.3.2 CANCER 84
9.3.3 CARDIAC DISEASES 85
9.3.4 AUTOIMMUNE DISEASES 86
9.3.5 ALZHEIMER’S DISEASE 88
9.3.6 ALLERGIES 89
9.4 COMPANION DIAGNOSTICS 91
9.5 OTHER APPLICATIONS 93
 
10 MULTIPLEX ASSAYS MARKET, BY END USER 94
10.1 INTRODUCTION 95
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 96
10.3 ACADEMIC & RESEARCH INSTITUTES 98
10.4 CLINICAL LABORATORIES 99
10.5 HOSPITALS 101
10.6 OTHER END USERS 103
 
11 GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION 104
11.1 INTRODUCTION 105
11.2 NORTH AMERICA 107
11.2.1 U.S. 112
11.2.2 CANADA 115
11.3 EUROPE 118
11.4 ASIA-PACIFIC 123
11.5 REST OF THE WORLD (ROW) 126
12 COMPETITIVE LANDSCAPE 128
12.1 OVERVIEW 128
12.2 COMPETITIVE SITUATION AND TRENDS 129
12.2.1 NEW PRODUCT LAUNCHES 130
12.2.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 131
12.2.3 ACQUISITION 132
12.2.4 OTHER STRATEGIES 133
 
13 COMPANY PROFILES 134
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 INTRODUCTION 134
13.2 LUMINEX CORPORATION 135
13.3 THERMO FISHER SCIENTIFIC INC. 139
13.4 ILLUMINA, INC. 141
13.5 BIO-RAD LABORATORIES INC. 143
13.6 QIAGEN N.V. 146
13.7 ABCAM PLC 148
13.8 BECTON, DICKINSON AND COMPANY 150
13.9 MERCK KGAA 152
13.10 SEEGENE INC. 154
13.11 MESO SCALE DIAGNOSTICS, LLC. 157
13.12 RANDOX LABORATORIES LTD. 158
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
14 APPENDIX 159
14.1 INSIGHTS OF INDUSTRY EXPERTS 159
14.2 DISCUSSION GUIDE 160
14.3 OTHER DEVELOPMENTS 164
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 168
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 170
14.6 AVAILABLE CUSTOMIZATIONS 172
14.7 RELATED REPORTS 173
 
List Of Tables
TABLE 1 GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 
2014–2021 (USD MILLION) 49
TABLE 2 GLOBAL MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY TYPE, 
2014–2021 (USD MILLION) 50
TABLE 3 GLOBAL MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 50
TABLE 4 NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 5 GLOBAL MULTIPLEX ASSAY INSTRUMENTS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 52
TABLE 6 NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 52
TABLE 7 GLOBAL MULTIPLEX ASSAY ACCESSORIES MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 53
TABLE 8 NORTH AMERICA: MULTIPLEX ASSAY ACCESSORIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 53
TABLE 9 GLOBAL MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 10 NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 11 GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 56
TABLE 12 GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 
2014–2021 (USD MILLION) 57
TABLE 13 GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 14 NORTH AMERICA: NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, 
BY COUNTRY, 2016–2021 (USD MILLION) 58
TABLE 15 GLOBAL PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 
2014–2021 (USD MILLION) 59
TABLE 16 NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 60
TABLE 17 GLOBAL BEAD-BASED NUCLEIC ACID ASSAYS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 60
TABLE 18 NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 61
TABLE 19 GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 
2014–2021 (USD MILLION) 62
TABLE 20 GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 63
TABLE 21 NORTH AMERICA: PROTEIN-BASED MULTIPLEX ASSAYS MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 64
TABLE 22 GLOBAL PLANAR PROTEIN ASSAYS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 64
TABLE 23 NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 65
TABLE 24 GLOBAL BEAD-BASED PROTEIN ASSAYS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 66
TABLE 25 NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 66
TABLE 26 GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014-2021 (USD MILLION) 68
TABLE 27 GLOBAL MULTIPLEX PCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 69
TABLE 28 NORTH AMERICA: MULTIPLEX PCR MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 69
TABLE 29 GLOBAL MULTIPLEX ARRAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 70
TABLE 30 GLOBAL MULTIPLEX ARRAYS MARKET SIZE, BY REGION, 
2014-2021 (USD MILLION) 71
TABLE 31 NORTH AMERICA: MULTIPLEX ARRAYS MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 71
TABLE 32 GLOBAL PLANAR ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 72
TABLE 33 NORTH AMERICA: PLANAR ARRAYS MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 72
TABLE 34 GLOBAL BEAD-BASED ARRAYS MARKET SIZE, BY REGION, 
2014-2021 (USD MILLION) 73
TABLE 35 NORTH AMERICA: BEAD-BASED ARRAYS MARKET SIZE, BY COUNTRY, 
2016–2021 (USD MILLION) 73
TABLE 36 GLOBAL OTHER TECHNOLOGIES MARKET SIZE, BY REGION, 
2014-2021 (USD MILLION) 74
TABLE 37 NORTH AMERICA: OTHER TECHNOLOGIES MARKET SIZE, BY COUNTRY, 
2016–2021 (USD MILLION) 74
TABLE 38 GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 76
TABLE 39 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION) 77
TABLE 40 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 78
TABLE 41 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 78
TABLE 42 GLOBAL MULTIPLEX ASSAYS DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 79
TABLE 43 NORTH AMERICA: MULTIPLEX ASSAYS DRUG DEVELOPMENT MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 44 GLOBAL MULTIPLEX ASSAYS BIOMARKER DISCOVERY & VALIDATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 80
TABLE 45 NORTH AMERICA: MULTIPLEX ASSAYS BIOMARKER DISCOVERY & VALIDATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 80
TABLE 46 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION) 81
TABLE 47 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 82
TABLE 48 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR DISEASE & DISORDER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 83
TABLE 49 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR INFECTIOUS DISEASES APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 83
TABLE 50 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR INFECTIOUS DISEASES APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 84
TABLE 51 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CANCER APPLICATIONS, 
BY REGION, 2014–2021 (USD MILLION) 84
TABLE 52 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CANCER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 85
TABLE 53 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CARDIAC DISEASES APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 85
TABLE 54 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CARDIAC DISEASES APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 55 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR AUTOIMMUNE DISEASES APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 87
TABLE 56 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR AUTOIMMUNE DISEASES APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 57 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR ALZHEIMER’S DISEASE APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 88
TABLE 58 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ALZHEIMER’S DISEASE APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 89
TABLE 59 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR ALLERGIES APPLICATIONS, 
BY REGION, 2014–2021 (USD MILLION) 90
TABLE 60 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ALLERGIES APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 90
TABLE 61 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR COMPANION DIAGNOSTICS, 
BY REGION, 2014-2021 (USD MILLION) 92
TABLE 62 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 63 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 93
TABLE 64 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 93
TABLE 65 GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 95
TABLE 66 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 97
TABLE 67 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION) 97
TABLE 68 GLOBAL MULTIPLEX ASSAY MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION) 98
TABLE 69 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION) 98
TABLE 70 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR CLINICAL LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 99
TABLE 71 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR CLINICAL LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 100
TABLE 72 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR HOSPITALS, BY REGION, 
2014–2021 (USD MILLION) 102
TABLE 73 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR HOSPITALS, 
BY COUNTRY, 2014–2021 (USD MILLION) 102
TABLE 74 GLOBAL MULTIPLEX ASSAYS MARKET SIZE FOR OTHERS END USERS, 
BY REGION, 2014-2021 (USD MILLION) 103
TABLE 75 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE FOR OTHER END USERS, 
BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 76 MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 106
TABLE 77 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 109
TABLE 78 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014–2021 (USD MILLION) 109
TABLE 79 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 
2014–2021 (USD MILLION) 109
TABLE 80 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 110
TABLE 81 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 111
TABLE 82 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 111
TABLE 83 U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 
2014–2021 (USD MILLION) 112
TABLE 84 U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 113
TABLE 85 U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 113
TABLE 86 U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 114
TABLE 87 U.S.: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 114
TABLE 88 CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 
2014–2021 (USD MILLION) 115
TABLE 89 CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 116
TABLE 90 CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 116
TABLE 91 CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 117
TABLE 92 CANADA: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 117
TABLE 93 EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 
2014–2021 (USD MILLION) 120
TABLE 94 EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 121
TABLE 95 EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 121
TABLE 96 EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 121
TABLE 97 EUROPE: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 122
TABLE 98 ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 2014–2021 (USD MILLION) 123
TABLE 99 ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 
2014–2021 (USD MILLION) 124
TABLE 100 ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 124
TABLE 101 ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 124
TABLE 102 ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 125
TABLE 103 ROW: MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT AND SERVICES, 
2014–2021 (USD MILLION) 126
TABLE 104 ROW: MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 126
TABLE 105 ROW: MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 127
TABLE 106 ROW: MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 127
TABLE 107 ROW: MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 127
TABLE 108 NEW PRODUCT LAUNCHES, 2016 130
TABLE 109 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2015 & 2016 131
TABLE 110 ACQUISITIONS, 2014-2016 132
TABLE 111 OTHER STRATEGIES, 2016 133
 
List Of Figures
FIGURE 1 RESEARCH DESIGN: MULTIPLEX ASSAYS MARKET 21
FIGURE 2 MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH 23
FIGURE 3 MULTIPLEX ASSAYS MARKET: BOTTOM-UP APPROACH 23
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION) 31
FIGURE 7 NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 
2016 VS. 2021 (USD MILLION) 31
FIGURE 8 PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 
2016 VS. 2021 (USD MILLION) 32
FIGURE 9 MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 
2016 VS. 2021 (USD MILLION) 32
FIGURE 10 MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 
2016 VS. 2021 (USD MILLION) 33
FIGURE 11 MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICES, 
2016 VS. 2021 (USD MILLION) 34
FIGURE 12 MULTIPLEX ASSAYS MARKET SIZE, BY END USERS, 2016 VS. 2021 (USD MILLION) 34
FIGURE 13 MULTIPLEX ASSAYS MARKET, BY REGION, 2016 (USD MILLION) 35
FIGURE 14 RISING FOCUS ON REDUCING OPERATIONAL COSTS—PRIMARY GROWTH DRIVER OF THE MULTIPLEX ASSAYS MARKET FROM 2016-2021 37
FIGURE 15 CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE 
IN 2016 38
FIGURE 16 APAC WILL BE THE FASTEST-GROWING MARKET FROM 2016 TO 2021 39
FIGURE 17 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2021 39
FIGURE 18 NUCLEIC ACID-BASED ASSAYS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016 40
FIGURE 19 MULTIPLEX ASSAYS MARKET SEGMENTATION 42
FIGURE 20 GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
FIGURE 21 CONSUMABLES SEGMENT TO DOMINATE THE MULTIPLEX ASSAYS PRODUCT AND SERVICES MARKET DURING THE FORECAST PERIOD 2016-2021 49
FIGURE 22 NORTH AMERICA TO DOMINATE MULTIPLEX ASSAY CONSUMABLES MARKET IN THE FORECAST PERIOD 2016-2021 51
FIGURE 23 THE PROTEIN MULTIPLEX ASSAYS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 2016-2021 56
FIGURE 24 THE U.S IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE NORTH AMERICAN NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET DURING THE FORECAST PERIOD 2016-2021 58
FIGURE 25 NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PLANAR NUCLEIC ACID ASSAYS MARKET DURING THE FORECAST PERIOD 
2016-2021 59
FIGURE 26 THE U.S. IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BEAD-BASED NUCLEIC ACID ASSAYS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 2016-2021 61
FIGURE 27 NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PROTEIN-BASED MULTIPLEX ASSAYS MARKET DURING THE FORECAST PERIOD 2016-2021 63
FIGURE 28 THE U.S IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE PLANAR PROTEIN ASSAYS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 2016-2021 65
FIGURE 29 MULTIPLEX ARRAYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2016-2021) 68
FIGURE 30 PLANAR ARRAYS TECHNOLOGY SEGMENT TO ACCOUNT FOR MORE THAN HALF OF THE MULTIPLEX ARRAYS MARKET IN 2016 70
FIGURE 31 NORTH AMERICA TO HOLD THE MAJOR SHARE IN THE PLANAR ARRAY TECHNOLOGY MARKET (2016–2021) 72
FIGURE 32 THE RESEARCH & DEVELOPMENT APPLICATION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD, 2016-2021 76
FIGURE 33 NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS DURING THE FORECAST PERIOD, 2016-2021 77
FIGURE 34 NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR DISEASE & DISORDER APPLICATIONS DURING THE FORECAST PERIOD, 2016-2021 82
FIGURE 35 NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET FOR COMPANION DIAGNOSTICS DURING THE FORECAST PERIOD, 2016-2021 91
FIGURE 36 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE MULTIPLEX ASSAYS MARKET, 2016-2021 95
FIGURE 37 NORTH AMERICA FORMS THE LARGEST SEGMENT IN THE MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2016-2021 96
FIGURE 38 U.S. TO DOMINATE THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET FOR CLINICAL LABORATORIES, 2016-2021 100
FIGURE 39 NORTH AMERICAN MARKET FOR HOSPITALS TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD, 2016-2021 101
FIGURE 40 GEOGRAPHIC SNAPSHOT (2016): ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION BY 2021 105
FIGURE 41 NORTH AMERICA PROVIDES GROWTH OPPORTUNITIES FOR THE MULTIPLEX ASSAYS MARKET, 2016 106
FIGURE 42 NORTH AMERICAN MULTIPLEX ASSAYS MARKET SNAPSHOT 108
FIGURE 43 R&D SEGMENT TO DOMINATE THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2021 110
FIGURE 44 U.S. MULTIPLEX BEAD ARRAYS SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR IN THE MARKET, BY TECHNOLOGY, 2016-2021 113
FIGURE 45 EUROPE MULTIPLEX ASSAYS MARKET SNAPSHOT 119
FIGURE 46 NUCLEIC ACID-BASED ASSAYS TO HOLD THE LARGEST SHARE IN THE EUROPEAN MARKET, BY TYPE, 2016-2021 120
FIGURE 47 PHARMA & BIOTECH SEGMENT EXPECTED TO COMMAND LARGEST SHARE IN THE APAC END-USER MARKET, 2016-2021 125
FIGURE 48 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY BETWEEN 2014–2016 128
FIGURE 49 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES—THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE MULTIPLEX ASSAYS MARKET FROM 2014-2016 129
FIGURE 50 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS, 2015 134
FIGURE 51 LUMINEX CORPORATION: COMPANY SNAPSHOT 135
FIGURE 52 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. 139
FIGURE 53 ILLUMINA, INC.: COMPANY SNAPSHOT 141
FIGURE 54 COMPANY SNAPSHOT: BIO-RAD LABORATORIES INC. 143
FIGURE 55 COMPANY SNAPSHOT: QIAGEN N.V. 146
FIGURE 56 ABCAM PLC: COMPANY SNAPSHOT 148
FIGURE 57 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 150
FIGURE 58 COMPANY SNAPSHOT: MERCK KGAA 152
FIGURE 59 COMPANY SNAPSHOT: SEEGENE INC. 154
 

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统